Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials

Schreiber, Stefan; Colombel, Jean‐Frédéric; G. Feagan, Brian; Reich, Kristian; Deodhar, Atul; B. McInnes, Iain; Porter, Brian; Das Gupta, Ayan; Pricop, Luminita; Fox, Todd

doi:10.1136/annrheumdis-2018-214273

Public

Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials

Published in Annals of the Rheumatic Diseases • Mar 12, 2019

Authors:

Stefan Schreiber

Jean‐Frédéric Colombel

Brian G. Feagan

Abstract

OBJECTIVES: Here, we present the reported incidence rates of inflammatory bowel disease (IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis (PsA) or ankylosing spondylitis (AS), in a pooled analysis of 21 clinical trials. METHODS: Data from all patients wh...

Subject

Medicine

Secukinumab

Ankylosing spondylitis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!